Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011849 (diabetes)
 277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

This study was conducted to investigate chromium metabolism and the effect of chromium supplementation in patients with Turner's syndrome, a condition noted for its high incidence of diabetes. Oral glucose tolerance tests were performed in 14 patients 8 to 19 yr of age. Eight of the 14 subjects were given 30 g of brewer's yeast containing 50 micrograms of chromium every day for 8 wk and glucose tolerance tests repeated. Urine samples were collected before and after each glucose load. Serum lipids were also investigated. Before supplementation, urinary chromium/creatinine ratio was high, and the urinary chromium response to oral glucose tolerance test was absent. Cholesterol and/or triglyceride levels were high in three of the patients. After supplementation, a decrease in urinary Cr/Cre ratio, and an improvement in glucose area index total were noted. A decrease in cholesterol and/or triglyceride levels occurred in the three patients with high initial levels as well as an increase in high-density lipoprotein cholesterol. These findings indicate a state of chromium deficiency and support the hypothesis that chromium deficiency may have a role in the pathogenesis of the abnormal glucose tolerance tests encountered in Turner patients.
 ...
PMID:Alterations of chromium metabolism and effect of chromium supplementation in Turner's syndrome patients. 662 99

Chromium is involved in normal glucose metabolism. To test whether chromium is also associated with the exercise-induced increases in glucose utilization, urinary chromium excretion, serum glucose, insulin, and glucagon of nine male runners (23-46 yr) were evaluated. Blood samples were taken prior to, immediately following, and 2 h after a strenuous 6-mile run. Urine samples were also taken at these times, and total daily urine collections were made the day of the run and the following day. Mean serum glucose for all runners immediately after running was 185 +/- 19 mg/dl compared with 90 +/- 1 mg/dl (mean +/- SE) prior to running. Mean serum glucagon immediately after running was significantly elevated compared with that observed prior to or 2 h after running; serum insulin levels were not altered significantly. Mean urinary chromium concentration was increased nearly five-fold 2 h after running; similar results were obtained when chromium concentration was expressed per mg of creatinine. Total daily urinary Cr excretion was approximately two times higher the day of running compared with the following nonrun day. Daily urinary excretion of sodium, potassium, and calcium were measured to determine if exercise had a general nonspecific effect on renal function; daily urinary excretion of these was not changed by exercise. These data demonstrate that accompanying the exercise-induced changes associated with increased glucose utilization, there is a significant increase in chromium excretion.
Diabetes 1982 Mar
PMID:Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. 675 38

Chromium(III) has been reported to be an essential trace element involved in the control of glucose metabolism by insulin. We have studied the distribution and kinetics of intravenous [51Cr]chromium(III) in six human subjects using a whole-body scintillation scanner, a whole-body counter, and plasma counting. Principal concentrations were found in the liver, spleen, soft tissue, and bone. The data were fit to a model consisting of a plasma pool in equilibrium with fast (T1/2 = 0.5-12 h), medium (1-14 days), and slow (3-12 mo) compartments, and transfer rates were calculated for exchanges between compartments. Each of the imaged organs appeared to contain varying proportions of each compartment. Two patients with hemochromatosis, in which iron overload is postulated to exclude chromium transport, were found to have altered rate constants. The results should be useful in assessing the metabolism and nutritional requirement of chromium(III) in humans and its importance in disease processes such as diabetes.
 ...
PMID:Kinetics of trace element chromium(III) in the human body. 683 62

The relation between plasma trivalent chromium (Cr3+), glucose tolerance and insulin secretion was studied in healthy volunteers and in patients with juvenile- or adult-onset diabetes mellitus. Cr3+ levels before and during the oral glucose tolerance test were not significantly different in the three groups, whereas glucose tolerance and insulin secretion were impaired in the diabetics. Our results indicate that plasma Cr3+ behavior does not reflect impairment of glucose tolerance and insulin secretion in diabetes mellitus.
 ...
PMID:Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus. 699 22

Twenty-four volunteers, mean age 78, including eight mildly non-insulin-dependent diabetics, were randomly allocated to one of two groups and were fed (daily for 8 wk) 9 g of either chromium-rich brewers' yeast (experimental) or chromium-poor torula yeast (control). Before and after yeast supplementation, the serum glucose and insulin response to 100 g oral glucose was measured at 30 min intervals for 2 h. Fasting serum cholesterol, total lipids, and triglycerides were also determined. In the total experimental group (normals + diabetics) and in both the diabetic and nondiabetic experimental subgroups, glucose tolerance improved significantly and insulin output decreased after supplementation. Cholesterol and total lipids fell significantly after supplementation in the total experimental group. The cholesterol decrease was particularly marked in hypercholesterolemic subjects (cholesterol > 300 mg/dl). In the control group, no significant change in glucose tolerance, insulin, triglycerides, or total lipids was found. Cholesterol was significantly lowered in the nondiabetic but not in the diabetic group. Thus, chromium-rich brewers' yeast improved glucose tolerance and total lipids in elderly subjects, while chromium-poor torula yeast did not. An improvement in insulin sensitivity also occurred with brewers' yeast supplementation. This supports the thesis that elderly people may have a low level of chromium and that an effective source for chromium repletion, such as brewers' yeast, may improve their carbohydrate tolerance and total lipids. The improvement in serum cholesterol in some control subjects, as well as in the total experimental group, also suggests the presence of a hypocholesterolemic factor other than chromium in both brewers' and torula yeast.
Diabetes 1980 Nov
PMID:Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. 700 May 89

Glucose Tolerance Factor (GTF) is synthesized in vivo from absorbed dietary chromium, and acts as a physiological enhancer of insulin activity, binding to insulin and potentiating its action about three-fold. Since GTF is well absorbed orally, the development of sufficiently concentrated and stable supplementary sources of this agent may enable convenient and physiologically appropriate pharmacological modulation of insulin activity. A review of the numerous physiological actions of insulin suggests a number of therapeutic applications for GTF, in such diverse ailments as diabetes mellitus, hyperlipidemia, reactive hypoglycemia, obesity, cancer, protein malnutrition or malabsorption, endogenous depression, Parkinsonism, hypertension and cardiac arrhythmias. GTF supplementation may also have value in preventive medicine.
 ...
PMID:The therapeutic potential of glucose tolerance factor. 700 27

Dispersed rat pancreatic islet cells were mixed into a short column of Bio-Gel P-2 polyacrylamide beads and perifused with an antiserum containing islet cell surface antibodies. The release of radioactive chromium from prelabeled cells, as a measure of cell membrane permeability, was not affected by cell surface antibodies alone, but increased dramatically in the presence of complement. While there was an eightfold increase in glucose-stimulated insulin release from beta-cells exposed to control serum and complement, insulin release was completely blocked from beta-cells exposed to islet-cell-specific antibodies and complement. These findings suggest that islet cell surface antibodies can mediate complement-dependent cytotoxicity.
Diabetes 1981 Mar
PMID:Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement. 700 72

The kidney is the principal route of excretion of the essential trace element chromium. Previous studies suggest that five to 40 percent of plasma chromium (III) is ultrafilterable and that 60 to 95 percent of filtered chromium is reabsorbed in the renal tubule. However, less than five percent of a stable Cr (III)-EDTA chelate is reabsorbed; therefore, this complex has been used to measure glomerular filtration. An increased fractional excretion of chromium may result from a glucose challenge or from a volume diuresis. These mechanisms have been postulated to cause an increased urinary excretion of chromium in patients with diabetes mellitus. Investigations of chromium metabolism and excretion must be interpreted with caution because chromium analysis is known to be subject to many sources of error and chromium (III) salts may not be physiologically equivalent to biological chromium complexes. Analytical refinements should permit further delineation of normal chromium homeostatic mechanisms and allow better identification of abnormalities in chromium metabolism.
 ...
PMID:Chromium (III) metabolism by the kidney. 703 38

Streptozotocin-induced diabetes was studied in male and female rats weighing 188 and 145 g, respectively, at the start of the experiment. After 79 days in the diabetic condition the weights and lengths of different bones were less in the diabetic rats than in two nondiabetic control groups, i.e., ad libitum fed and a group restricted in food intake to achieve the same body weight as the diabetic rats. The concentrations of calcium, phosphorus, and sodium were similar in the diabetic and nondiabetic groups, whereas the concentrations of iron and zinc were higher in the diabetic rats. Results for the concentration of potassium, magnesium, and chromium showed a less uniform pattern between groups and between males and females. It is concluded that the length and weight of bones in diabetic rats are less than nondiabetic rats of the same body weight. This results in a lower total amount of calcium, phosphorus, sodium, potassium, magnesium, and chromium. This observation was similar in all three bones studied. Therefore, prolonged streptozotocin-induced diabetes does interfere with the normal pattern of bone mineralization.
 ...
PMID:Mineralization of different bones in streptozotocin-diabetic rats: study on the concentration of eight minerals. 728 93

The intravenous injection of zinc chloride immediately before and 15 minutes after alloxan or dithizone prevented the usual hyperglycaemia observed 24 hours after induction of diabetes. The intravenous injection of manganese chloride prevented any marked rise of blood glucose, while chromium and cobalt chlorides lowered the blood glucose level to a certain extent. In alloxan diabetic rats, serum GOT and GPT levels were significantly higher than normal. The serum GOT levels were higher in animals injected with chromium than cobalt, zinc and manganese; while serum GPT levels were higher in cobalt than in chromium, zinc and manganese. In dithizone diabetes, serum GOT and GPT were increased in animals injected with cobalt than chromium, zinc and manganese. Alloxan diabetic rats showed lower serum alkaline phosphatase levels and higher in animals injected with cobalt than chromium, zinc and manganese. For dithizone, there are statistically significant differences in all cases. In alloxan diabetes, coeruloplasmin was higher than normal, while intravenous injection of dithizone was without effect on serum coeruloplasmin.
 ...
PMID:Serum enzyme changes due to trace amounts of some transition metal ions on the induction of experimental diabetes. 742 63


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>